EN DE
Watch Elite Health Systems Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Elite Health Systems Inc (EHSI) fair value: what the stock is really worth

As of Nov 13, 2026: fair value (intrinsic value) of Elite Health Systems Inc stock $0.61, price $0.83, that is 26.3% below the price, quality 27 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US

EH Elite Health Systems Inc logo Thin data Nov 10, 2026

Elite Health Systems Inc

EHSI · US

Expensive (fair value 26% below the price), weak company and falling price: meets none of the 3 rules.

Get notified free when this changes
Insiders bought $46,300 (6M) 
Fair value $0.6114 · Overvalued 
Quality 27/100 
Falling price (downtrend) 
Weak Growth 
Negative free cash flow 
Trails peers (0/8) 
Narrow moat 5/100 · thin data
Thin data 
Estimate⚠ Thinly traded
Watch Elite Health Systems Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$1.90 $0.0400 Fair Value $0.6114 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range $0.0400 – $1.90 · fair‑value band $0.4586 – $0.7643 · the $0.8300 price screens above the $0.6114 fair value. As of Nov 10, 2026.

Follow Elite Health Systems in your weekly email

Every Wednesday you see whether Elite Health Systems is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Elite Health Systems Inc., through its subsidiaries, develops a business to provide Medicare Advantage plans and other healthcare related services in California and Nevada. The company also focuses on improving and providing access to healthcare, primarily for seniors and special needs groups.

Show moreShow less

The company was formerly known as U.S. NeuroSurgical Holdings, Inc. and changed its name to Elite Health Systems Inc. in September 2024. Elite Health Systems Inc. was founded in 1993 and is headquartered in Ontario, California.

Stock analysis

Elite Health Systems Inc (EHSI) currently trades at $0.8300, while our estimate is $0.6114, 26% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: $0.4586 (bear) to $0.7643 (bull), the price of $0.8300 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 27/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak, negative or inconsistent.

Elite Health Systems Inc reported revenue of $1.0M in FY2025 versus $1.1M in FY2021, a compound −0.9%/yr. Reported net income was −$7.8M in FY2025.

Key figures

Market cap $23.7M Micro · P/S ratio 6.50 · EPS (TTM) $−0.4000 · Return on equity −307% · Return on assets (EBIT) −47.7% (5-year average) · Operating margin −118% · Free cash flow −$4.0M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 5 out of 100 (low confidence).

What moves the price

The share trades about 45% below its 52-week high and 21% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −2% fair-value upside, at −26%, EHSI screens richer than that median.

Fair Value

Bear $0.4586 Fair Value $0.6114 Bull $0.7643
Price $0.8300 · Downside -26.3%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 27/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 1
How much profit the company makes from its sales and capital
Quality Growth 50
Are margins and returns getting better?
Cashflow 0
Do the profits arrive as real cash?
Financial strength 97
Debt, balance sheet and risk of trouble
Investment 0
Does it invest with discipline instead of growing at any price?
Low Volatility 59
How calm the share price moves, does not count
Price momentum 17
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 9
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, one officer or director bought shares worth $46,300, on Jul 2, 2026.

  • BuyPrasad Anjaneya jeereddiCEO, Director, 10% owner4× since Jan 6, 2026: 59,414 shares, avg. $1.00$59,554Jul 2, 2026

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 13, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is weak, negative or inconsistent.
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−8.3% (2021) → −374.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

EHSI screens overvalued: fair value 26% below the price. Compare with HCA Healthcare, Inc →

Compare Elite Health Systems Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 249 stocks

Beats the industry median on 0/7 measures
Overall it trails its industry peers.
Valuation
Quality Score 27 · Bottom 25%
Fair Value upside −26.3% · Below median
Profitability
Return on assets −117.1% · Bottom 25%
Operating margin (12 months) −117.6% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 0.0% · Bottom 25%

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/B 4.46× · Priciest 25%
P/S (12 months) 6.35× · Priciest 25%

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Fresenius Medical Care AG FMS $22.03 $45.73 +108% vs EHSI
DaVita Inc DVA $174.56 $218.90 +25% vs EHSI
Aier Eye Hospital Group 300015 ¥8.84 ¥10.88 +23% vs EHSI
HCA Healthcare, Inc HCA $499.05 $547.34 +10% vs EHSI
Tenet Healthcare Corporation THC $286.03 $279.20 −2% vs EHSI
The Ensign Group ENSG $188.41 $140.09 −26% vs EHSI
Encompass Health Corporation EHC $140.99 $94.81 −33% vs EHSI
Fresenius SE FRE €53.62 €34.77 −35% vs EHSI
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,526 ₹5,234 −39% vs EHSI
Dr. Sulaiman Al Habib Medical Services Group 4013 212.10 SAR 109.45 SAR −48% vs EHSI

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Elite Health Systems Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Elite Health Systems Inc Fair Value". https://www.fairvalue-calculator.com/stock/EHSI

Frequently asked questions

Is Elite Health Systems Inc (EHSI) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is $0.6114 versus a price of $0.8300, about 26% lower (overvalued).
What is the fair value of EHSI?
Our estimate for Elite Health Systems Inc is $0.6114 (as of Nov 10, 2026), built from audited fundamentals. The current price: $0.8300.
What is the quality score of EHSI?
Elite Health Systems Inc has a Quality Score of 27/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Elite Health Systems Inc (EHSI)?
Our calculated price target is the estimate of $0.6114 (as of Nov 10, 2026). Cautious scenario $0.4586, optimistic scenario $0.7643. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Elite Health Systems Inc stock forecast for 2026?
Our estimate puts fair value at $0.6114, about 26% lower versus a price of $0.8300 (overvalued). Cautious scenario $0.4586, optimistic scenario $0.7643. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Elite Health Systems Inc (EHSI)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Elite Health Systems Inc it is $0.6114 per share (as of Nov 10, 2026), against a price of $0.8300.
Is Elite Health Systems Inc stock overvalued or undervalued in 2026?
As of Nov 10, 2026, EHSI trades above its calculated fair value: price $0.8300, fair value $0.6114, a gap of about −26% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of EHSI?
No. The price is what the market pays today ($0.8300); the fair value is what the company's own numbers justify ($0.6114). For Elite Health Systems Inc the two are $0.2186 per share apart. That gap is exactly why we show both numbers side by side.
How much is Elite Health Systems Inc worth?
The market values Elite Health Systems Inc at about $23.7M (market capitalisation, as of Nov 10, 2026). Per share that is $0.8300; our models calculate a fair value of $0.6114 per share.
What do the bullish and bearish scenarios say about EHSI?
Our models span a range for Elite Health Systems Inc: cautious scenario $0.4586, base $0.6114, optimistic $0.7643 per share (as of Nov 10, 2026, price $0.8300). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Elite Health Systems Inc (EHSI)?
Balance-sheet figures for Elite Health Systems Inc (as of Nov 10, 2026): return on equity −307.3%. They feed the Quality Score of 27/100, which measures business quality independently of the share price.
How far is EHSI from its 52-week high?
Elite Health Systems Inc trades at $0.8300, about 45% below its 52-week high of $1.50 and 21% above the low of $0.6839 (as of Nov 13, 2026). Distance from the high says nothing about value: that is what the fair value of $0.6114 is for.
Which stocks are comparable to Elite Health Systems Inc?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Elite Health Systems Inc stock attractive at the current price?
The data as of Nov 10, 2026: price $0.8300, calculated fair value $0.6114 (−26%), Quality Score 27/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5% above its aggregate fair value. Elite Health Systems Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Elite Health Systems Inc (EHSI)?
The closing price on Nov 13, 2026 was $0.8300. Our estimate is $0.6114, about 26% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Elite Health Systems Inc right now?
The price sits above even our optimistic bull case ($0.7643). The favourable scenario is already priced in. Weak quality (27/100) and above fair value at the same time, the margin of safety is missing on both counts. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Elite Health Systems Inc

How large is the market capitalisation of Elite Health Systems Inc (EHSI)?
The market capitalisation of Elite Health Systems Inc is $23.7M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Elite Health Systems Inc (EHSI)?
The price-to-sales ratio of Elite Health Systems Inc is 6.50 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Elite Health Systems Inc (EHSI)?
Earnings per share at Elite Health Systems Inc are $−0.4000. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Elite Health Systems Inc (EHSI)?
The return on equity (ROE) of Elite Health Systems Inc is −307% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Elite Health Systems Inc (EHSI)?
On an EBIT basis the return on assets of Elite Health Systems Inc is −47.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Elite Health Systems Inc (EHSI)?
The operating margin of Elite Health Systems Inc is −118% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How much free cash flow does Elite Health Systems Inc (EHSI) generate?
The free cash flow of Elite Health Systems Inc is −$4.0M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch Elite Health Systems Inc in the live analysis

One click puts Elite Health Systems Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.